Henry Butt
Henry L. Butt, MSc, PhD, is the Director of Bioscreen (a laboratory specializing in fecal microbial analysis) and a researcher in Newcastle, Australia.
Contents
Books[edit | edit source]
- 2014, Chapter Five in Advances in Clinical Chemistry, Vol. 66, published by Elsevier; "Metabolism in Chronic Fatigue Syndrome," by Christopher W. Armstrong, Neil R. McGregor, Henry L. Butt, and Paul R. Gooley[1]
Notable studies[edit | edit source]
- 1996, Preliminary determination of the association between symptom expression and urinary metabolites in subjects with chronic fatigue syndrome
- 1996, Preliminary determination of a molecular basis of chronic fatigue syndrome
- 1997, A Preliminary Assessment of the Association of SCL-90-R Psychological Inventory Responses with Changes in Urinary Metabolites in Patients with Chronic Fatigue Syndrome[2]
- 1998, Immunological and Haematological Parameters in Patients with Chronic Fatigue Syndrome[3] - (Abstract)
- 2000, Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome[4]
- 2000, Erythrocyte Morphology in Rheumatoid Arthritis and Chronic Fatigue Syndrome: A Preliminary Study[5]
- 2000, Investigation of Erythrocyte Oxidative Damage in Rheumatoid Arthritis and Chronic Fatigue Syndrome[6]
- 2007, Hematologic and urinary excretion anomalies in patients with chronic fatigue syndrome[7] - (Abstract)
- 2009, Increased D-Lactic Acid Intestinal Bacteria in Patients with Chronic Fatigue Syndrome[8]
- 2014, Metabolism in chronic fatigue syndrome[9] - (Abstract)
- 2015, Sleep quality and the treatment of intestinal microbiota imbalance in Chronic Fatigue Syndrome: A pilot study (Jackson ML, Henry Butt, Ball M, Lewis DP, Bruck D)
- 2015, Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients[10]
- 2016, Widespread pain and altered renal function in ME/CFS patients[11]
- 2016, Support for the Microgenderome: Associations in a Human Clinical Population[12] - (Full Text)
- 2017, Examining clinical similarities between myalgic encephalomyelitis/chronic fatigue syndrome and d-lactic acidosis: a systematic review[13] - (Full Text)
- 2017, The association of fecal microbiota and fecal, blood serum and urine metabolites in myalgic encephalomyelitis/chronic fatigue syndrome[14]
- 2018, Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons[15] - (Full Text) (Correction)
- 2012, NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome[16] - (Abstract)
Talks and interviews[edit | edit source]
Online presence[edit | edit source]
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- ↑ Armstrong, Christopher W.; McGregor, Neil R.; Butt, Henry L.; Gooley, Paul R. (2014). "Metabolism in Chronic Fatigue Syndrome". Advances in Clinical Chemistry: 121–172.
- ↑ N.R. McGregor, R.H. Dunstan, H.L. Butt, T.K. Roberts, I.J. Klineberg, and M. Zerbes. (1997). A Preliminary Assessment of the Association of SCL-90-R Psychological Inventory Responses with Changes in Urinary Metabolites in Patients with Chronic Fatigue Syndrome. Journal of Chronic Fatigue Syndrome, Vol. 3, Iss. 1, pp 17-37. http://dx.doi.org/10.1300/J092v03n01_03
- ↑ Roberts, Timothy K.; McGregor, Neil R.; Dunstan, R. Hugh; Donohoe, Mark; Murdoch, Raymond N.; Zhang, S.; Hope, D.; Butt, Henry L.; Watkins, Jennifer A.; Taylor, Warren G. (1998). "Immunological and Haematological Parameters in Patients with Chronic Fatigue Syndrome". Journal of Chronic Fatigue Syndrome. 4 (4): 51–65. doi:10.1300/J092v04n04_05.
- ↑ Richards, RS; Roberts, TK; McGregor, NR; Dunstan, RH; Butt, HL (2000), "Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome", Redox Report, 5 (1): 35-41, doi:10.1179/rer.2000.5.1.35, PMID 10905542
- ↑ R. S. Richards, T. K. Roberts, D. Mathers, R. H. Dunstan, N. R. McGregor & H. L. Butt. (2000). Erythrocyte Morphology in Rheumatoid Arthritis and Chronic Fatigue Syndrome: A Preliminary Study. Journal of Chronic Fatigue Syndrome, Vol. 6, Iss. 1, pp. 23-35. http://dx.doi.org/10.1300/J092v06n01_03
- ↑ R. S. Richards, T. K. Roberts, D. Mathers, R. H. Dunstan, N. R. McGregor & H. L. Butt. (2000). Investigation of Erythrocyte Oxidative Damage in Rheumatoid Arthritis and Chronic Fatigue Syndrome. Journal of Chronic Fatigue Syndrome, Vol. 6, Iss. 1, pp. 37-46. http://dx.doi.org/10.1300/J092v06n01_04
- ↑ Niblett, Suzanne H.; King, Katrina E.; Dunstan, R. Hugh; Clifton-Bligh, Phillip; Hoskin, Leigh A.; Roberts, Timothy K.; Fulcher, Greg R.; McGregor, Neil R.; Dunsmore, Julie C.; Butt, Henry; Klineberg, Iven; Rothkirch, T. B. (September 2007). "Hematologic and Urinary Excretion Anomalies in Patients with Chronic Fatigue Syndrome". Experimental Biology and Medicine. 232 (8): 1041–1049. doi:10.3181/0702-rm-44. ISSN 1535-3702.
- ↑ Sheedy, John R.; Wettenhall, Richard E. H.; Scanlon, Denis; Gooley, Paul R.; Lewis, Donald P.; McGregor, Neil; Stapleton, David I.; Butt, Henry L.; De Meirleir, Kenny L. (July 2009). "Increased d-lactic Acid intestinal bacteria in patients with chronic fatigue syndrome". In Vivo (Athens, Greece). 23 (4): 621–628. ISSN 0258-851X. PMID 19567398.
- ↑ Armstrong, Christopher W.; McGregor, Neil R.; Butt, Henry L.; Gooley, Paul R. (2014). "Metabolism in chronic fatigue syndrome". Advances in Clinical Chemistry. 66: 121–172. ISSN 0065-2423. PMID 25344988.
- ↑ Armstrong, Christopher W.; McGregor, Neil R.; Lewis, Donald P.; Butt, Henry L.; Gooley, Paul R. (2015), "Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients", Metabolomics, 11 (6): 1626–1639, doi:10.1007/s11306-015-0816-5
- ↑ McGregor, Neil R.; Armstrong, Christopher W.; Lewis, Donald P.; Butt, Henry L.; Gooley, Paul R. (July 2016). "Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients". Fatigue: Biomedicine, Health & Behavior. 4 (3): 132–145. doi:10.1080/21641846.2016.1207400.
- ↑ Wallis, Amy; Butt, Henry L; Ball, Michelle; Lewis, Donald P; Bruck, Dorothy (January 13, 2016), "Support for the Microgenderome: Associations in a Human Clinical Population", Scientific Reports, 6: 19171, doi:10.1038/srep19171, PMID 26757840
- ↑ Wallis, Amy; Ball, Michelle; McKechnie, Sandra; Butt, Henry L; Lewis, Donald P; Bruck, Dorothy (2017), "Examining clinical similarities between myalgic encephalomyelitis/chronic fatigue syndrome and d-lactic acidosis: a systematic review", Journal of Translational Medicine (15): 129, doi:10.1186/s12967-017-1229-1
- ↑ Armstrong, Christopher W.; McGregor, Neil R.; Lewis, Donald P.; Butt, Henry L.; Gooley, Paul R. (2017), "The association of fecal microbiota and fecal, blood serum and urine metabolites in myalgic encephalomyelitis/chronic fatigue syndrome", Metabolomics, 13 (1), doi:10.1007/s11306-016-1145-z
- ↑ Wallis, Amy; Ball, Michelle; Butt, Henry L; Lewis, Donald P; McKechnie, Sandra; Paull, Phillip; Jaa-Kwee, Amber; Bruck, Dorothy (2018), "Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons", Journal of Translational Medicine, 16 (1): 24, doi:10.1186/s12967-018-1392-z
- ↑ Armstrong, Christopher W.; McGregor, Neil R.; Sheedy, John R.; Buttfield, Ian; Butt, Henry L.; Gooley, Paul R. (2012), "NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome", Clinica Chimica Acta, 413 (19–20): 1525–1531, doi:10.1016/j.cca.2012.06.022
metabolite A chemical compound produced by, or involved in, metabolism. The term is often used to refer to the degradation products of drugs in the body.
microbiome The full collection of microscopic organisms (especially bacteria and fungi) which are present in a particular environment, particularly inside the human body.
serum The clear yellowish fluid that remains from blood plasma after clotting factors have been removed by clot formation. (Blood plasma is simply blood that has had its blood cells removed.)
metabolite A chemical compound produced by, or involved in, metabolism. The term is often used to refer to the degradation products of drugs in the body.
serum The clear yellowish fluid that remains from blood plasma after clotting factors have been removed by clot formation. (Blood plasma is simply blood that has had its blood cells removed.)
metabolomics The analysis of the chemical metabolism within cells, tissues or organisms. The term is often used to refer to the full set of metabolites found in a cell in a given environment.
The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.
